Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common variable immunodeficiency.

M C Sneller1

  • 1Laboratory of Immunoregulation, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland 20892, USA. msneller@niaid.nih.gov

The American Journal of the Medical Sciences
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Journal of viral hepatitis·2016
Same author

HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence?

HIV medicine·2013
Same author

Orbital socket contracture: a complication of inflammatory orbital disease in patients with Wegener's granulomatosis.

The British journal of ophthalmology·2005
Same author

Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia.

The Journal of infectious diseases·2004
Same author

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

Blood·2001
Same author

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.

Blood·2001
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Common variable immunodeficiency (CVI) is a complex immune disorder causing recurrent infections, autoimmune diseases, and malignancy. This review covers CVI

Area of Science:

  • Immunology
  • Clinical Medicine

Background:

  • Common variable immunodeficiency (CVI) is a heterogeneous primary immunodeficiency.
  • Characterized by hypogammaglobulinemia, recurrent bacterial infections, and immune dysregulation.
  • Associated with increased risks of autoimmune disease and malignancy.

Purpose of the Study:

  • To provide a comprehensive review of CVI.
  • Discuss pathogenesis, clinical manifestations, diagnosis, and treatment.
  • Highlight the broad spectrum of CVI-associated conditions.

Main Methods:

  • Literature review of CVI.
  • Synthesis of current knowledge on pathogenesis.
  • Compilation of clinical, diagnostic, and therapeutic information.

Related Experiment Videos

Main Results:

  • CVI presents with diverse immunological abnormalities.
  • Patients experience recurrent infections and are at higher risk for autoimmunity and cancer.
  • Management requires multidisciplinary specialist involvement.

Conclusions:

  • CVI is a multifaceted syndrome requiring thorough understanding.
  • Early diagnosis and comprehensive management are crucial for patient outcomes.
  • Further research into CVI pathogenesis may reveal novel therapeutic targets.